Redhill Biopharma Ltd. (RDHL) Fundamentals

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.
SHARE INFORMATION
Market Cap$ 61,270,521
Shares Outstanding63,823,459
Float63,823,459
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 85,757,000
Latest Fiscal EPS$ -2.10
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions89
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months112,554
Institutional Holdings Percent9.6%
Institutional Sold Previous 3 Months502,227
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 11.18
52 Week Low$ 0.62
52 Week High Change$ -86.52
21 Day Moving Average$ 0.9213
21 Day Extended Moving Average$ 0.932865
50 Day Moving Average$ 0.9046
50 Day Extended Moving Average$ 1.0089
200 Day Moving Average$ 2.1443
200 Day Extended Moving Average$ 2.3303
10 Day Average Volume1,591,733
20 Day Average Volume1,299,506
30 Day Average Volume2,305,476
50 Day Average Volume3,583,645
Alpha-0.032089
Beta1.8582
Standard Deviation0.224900
R20.170766
7 Day Price Change$ 0.0498
7 Day Percent Change5.47%
21 Day Price Change$ 0.0633
21 Day Percent Change7.06%
30 Day Price Change$ -0.10
30 Day Percent Change-9.43%
Month to Date Price Change$ 0.09
Month to Date Percent Change10.34%
Quarter to Date Price Change$ 0.09
Quarter to Date Percent Change10.34%
180 Day Price Change$ -1.45
180 Day Percent Change-60.17%
200 Day Price Change$ -1.65
200 Day Percent Change-63.22%
Year to Date Price Change$ -1.62
Year to Date Percent Change-62.79%

Redhill Biopharma Ltd. (RDHL) Key Ratios

PROFITABILITY
EBIT Margin-91.5%
EBITDA Margin-69.9%
Pre-Tax Profit Margin-500.4%
Profit Margin Count-96.73%
Gross Margin43.4%
Profit Margin TOT-96.73%
INCOME STATEMENTS
Revenue$ 61,916,000
Revenue Per Share$ 0.9701
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-12.50
Total Debt To Equity9.90
Int Coverage-4.90
Current Ratio1.00
Leverage Ratio101.10
Quick Ratio0.70
Long Term Debt To Capital0.91
VALUATION MEASURES
PE Ratio-0.50
Enterprise Value$ 129,274,783
Price to Sales0.989575
Price to Free Cash-1.70
PE High Last 5 Years-4.60
Price To Book4.60
Price To Cash Flow0.00
PE Low Last 5 Years-6.50
Price to Tangible Book-12.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.40
Invoice Turnover4.20
Assets Turnover0.40
Return Assets-49.09
Return on Equity-410.40
Return on Capital-66.26

Redhill Biopharma Ltd. (RDHL) Profile

PROFILE INFO
Issue TypeCS
SEC TypeDR
AuditorKesselman & Kesselman C.P.A.s
CEODror Ben-Asher
Emplyoees120
Last AuditUQ
CIK0001553846
IndustryDrug Manufacturers
SectorHealthcare
NAICS-
CONTACT INFO
Address21 Ha'arba'a Street
Tel Aviv, 6473921
Websitehttps://www.redhillbio.com
Facsimile+972 35413144
Telephone+972 35413131
Emailinvestors@redhillbio.com
Your Recent History
NASDAQ
RDHL
Redhill Bo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220815 00:45:50